Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
When hospital 6, which seemed to confer an idiosyncratic benefit to patients, is excluded the 90 day survival was marginally lower in the hospitals in which pharmaceutical thromboprophylaxis was used routinely than in those in which it was not (table). The mortality from causes other than pulmonary embolism was significantly higher in the hospitals in which prophylaxis was used routinely
2=5.5, P=0.02).
90 Day survival and mortality from pulmonary embolism
according to use of prophylaxis (figures are numbers
(percentages))
------------------------------------------------------------
Death due to:
------------------------------------------------------------
No of |
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?